Akili expands its prescription video game portfolio with $37M offer for Tali's attention-improving tech

Retrieved on: 2021-08-17 16:07:30

Tags for this article:

Amphetamine

Psychiatry

Childhood psychiatric disorders

Methylphenidate

Abnormal psychology

Neuroscience

Educational psychology

Attention deficit hyperactivity disorder

Cognitive disorder

Adam Gazzaley

Attention deficit hyperactivity disorder management

Tali Digital

Click the tags to see associated articles and topics

Akili expands its prescription video game portfolio with $37M offer for Tali's attention-improving tech. View article details on hiswai:

Excerpt

Akili will offer up the expertise it gained from bringing its own prescription video game treatment through the clinical development and FDA clearance ...

Article found on: www.fiercebiotech.com

View Original Article